Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Lerato Sheila Thamahane.

Lerato Thamahane may be able to speak and understand all nine of South Africa’s official African languages, but it is a tenth language she is devoting her life to: South African Sign Language (SASL).

With nearly ten years’ experience as a SASL interpreter in several settings – ranging from the medical and mental-health fields to that of conferences and Deafblind interpreting – Lerato is living her life’s purpose. “I regard myself as a member of the Deaf community and a servant at the same time.”

Lerato lives by the principle that the more perspectives she gains on the world, the better service as an interpreter she can provide. This is also part of the reason why Lerato decided to take on the role of student again to study BA Language Practice to provide her with an even broader perspective on the field. 

But why does Lerato feel so strongly about SASL? It is only through Sign Language, Lerato explains, that one can bridge the divide between the world of the hearing and that of the Deaf. “SASL is the only way for the minority Deaf group to receive and transfer information,” Lerato emphasises. “Deaf people cannot communicate in any other way.” Now, consider for a moment the plight of a Deaf child in South Africa. To receive education in SASL, most Deaf children have to move far away from home at a very young age in order to attend a school for the Deaf. For many years, schools for the Deaf did not include other languages as subjects, which prevented Deaf school-leavers from entering higher education. Although this situation has largely changed, Deaf students are still fighting an uphill battle when entering higher education institutions where prejudice and ignorance still persist. This is where the work of the Centre for Universal Access and Disability Support (CUADS) and the Department of South African Sign Language (SASL) and Deaf Studies makes such a crucial difference.

“I firmly believe,” Lerato says, “that only Sign Language can open opportunities for all groups of the Deaf community – from Deaf children to adults, and from the uneducated to the most educated Deaf people.” It is for this reason, Lerato argues, that our constitution needs to recognise SASL in order to give Deaf people full and equal access to information, to education, and ultimately, to all the opportunities South Africa has to offer.


News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept